Back to BLAIR WILLIAM & CO/IL BLAIR WILLIAM & CO/IL

GALTGALT
28 quarters

Position history for BLAIR WILLIAM & CO/ILBLAIR WILLIAM & CO/IL's holdings in GALECTIN THERAPEUTICS INC

BLAIR WILLIAM & CO/IL holds 149,283 shares of GALT (GALECTIN THERAPEUTICS INC), worth $692,673 as of 2026-Q2. GALT represents 0.0% of BLAIR WILLIAM & CO/IL's portfolio.

Current Value

$692,673

Current Shares

149,283

Total Value Change

+$647,673

Total Shares Change

+138,527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
149,283
0.0%
$692,6730.0%$4.64
0
2026-Q1
Increased
149,283
+294.1%
$416,5000.0%$2.98
39
2025-Q4
Unchanged
37,884
0.0%
$157,5970.0%$4.08
0
2025-Q3
Unchanged
37,884
0.0%
$160,4390.0%$4.22
0
2025-Q2
Unchanged
37,884
0.0%
$79,9350.0%$2.33
0
2025-Q1
Unchanged
37,884
0.0%
$46,2180.0%$1.52
0
2024-Q4
Unchanged
37,884
0.0%
$48,8700.0%$1.10
0
2024-Q3
Unchanged
37,884
0.0%
$104,1810.0%$2.71
0
2024-Q2
Unchanged
37,884
0.0%
$85,6180.0%$2.26
0
2024-Q1
Unchanged
37,884
0.0%
$90,5430.0%$2.39
0
2023-Q4
Unchanged
37,884
0.0%
$62,8870.0%$1.66
0
2023-Q3
Unchanged
37,884
0.0%
$72,7370.0%$1.92
0
2023-Q2
Unchanged
37,884
0.0%
$54,5530.0%$1.39
0
2023-Q1
Unchanged
37,884
0.0%
$79,5560.0%$2.17
0
2022-Q4
Decreased
37,884
-7.3%
$42,8090.0%$1.13
0
2022-Q3
Unchanged
40,884
0.0%
$67,0000.0%$1.65
0
2022-Q2
New
40,884
-
$54,0000.0%$1.25
29
2021-Q4
Exited
0
-100.0%
$00.0%$2.11
0
2021-Q3
Unchanged
10,756
0.0%
$42,0000.0%$3.82
0
2021-Q2
Unchanged
10,756
0.0%
$34,0000.0%$3.45
0
2021-Q1
Unchanged
10,756
0.0%
$23,0000.0%$2.03
0
2020-Q4
Unchanged
10,756
0.0%
$24,0000.0%$2.30
0
2020-Q3
Unchanged
10,756
0.0%
$29,0000.0%$3.30
0
2020-Q2
Unchanged
10,756
0.0%
$33,0000.0%$3.04
0
2020-Q1
Decreased
10,756
-68.5%
$21,0000.0%$1.98
0
2019-Q4
Unchanged
34,120
0.0%
$98,0000.0%$2.80
0
2019-Q3
Increased
34,120
+217.2%
$125,0000.0%$3.63
36
2019-Q2
New
10,756
-
$45,0000.0%$4.15
28

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used